Last reviewed · How we verify

Activated Prothrombin Complex Concentrate

Hoffmann-La Roche · Phase 2 active Small molecule

Activated Prothrombin Complex Concentrate works by replacing clotting factors to help the blood to clot.

Activated Prothrombin Complex Concentrate works by replacing clotting factors to help the blood to clot. Used for Treatment of bleeding episodes in patients with hemophilia A or B, Treatment of bleeding in patients with acquired hemophilia A.

At a glance

Generic nameActivated Prothrombin Complex Concentrate
SponsorHoffmann-La Roche
Drug classCoagulation factor replacement therapy
ModalitySmall molecule
Therapeutic areaHematology
PhasePhase 2

Mechanism of action

It is used to treat bleeding episodes in patients with hemophilia A or B, and in patients with acquired hemophilia A. Activated Prothrombin Complex Concentrate contains a mixture of clotting factors that are necessary for blood to clot.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results